Figure 1. Severe exophthalmos.
Figure 2. Abnormal tissue completely occupying the orbital spaces, slightly infiltrating the anterior fossa up to the sella.
Figure 3. Orbital tissue. Left, Sheets of large, pale to eosinophilic polygonal histiocytic cells with large vesicular nuclei and small nucleoli; occasional multinucleated histiocytes and spindle-shaped histiocytes were also present (hematoxylin-eosin, original magnification ×150). Right, The histiocytic cells stained positive for S100 protein (alkaline phosphatase anti–alkaline phosphatase, original magnification ×150).
Rosai-Dorfman disease (RDD) is an uncommon proliferative disorder of histiocytes that was first described in 1969.1
Generally, RDD is characterized by massive lymphadenopathy (frequently accompanied by anemia), increased erythrocyte sedimentation rate, and elevated levels of serum immunoglobulins. Histologically, this condition is characterized by a proliferation of large pale cells that show striking lymphocytophagocytosis (emperipolesis) and immunoreactivity for S100 protein.2 However, it has only recently been described as a distinct entity in soft tissue, with pernicious locally recurrent lesions.3,4
The disease is often not recognized in the soft tissue.3,4 Emperipolesis can be less conspicuous and proliferating histiocytes are spindled, associated with collagen deposition, and arranged in a vague storiform pattern with scattered lymphoplasmacytic aggregates. Lymph node involvement can be present or not.3
These features lead to a variety of misdiagnoses, including benign inflammatory and fibrohistiocytic lesions, lymphoma, and malignant fibrous histiocytoma.3
Rosai-Dorfman disease of the soft tissue occurs more often in older patients than does nodal RDD.3 Areas involved can include face, leg, arm, shoulder, abdomen, groin, buttock, back, retroperitoneum, orbit, and chest wall.3- 5
Optimal therapy has not been established.6 Knowing that RDD of soft tissue mimics fibrous and inflammatory lesions of soft tissue is important for prompt diagnosis and selection of the most appropriate therapy.
Accepted for publication May 19, 1999.
Reprints: Raffaella Zannolli, MD, Instituto di Clinica Pediatrica, Universita Degli Studi di Siena, via della Scotte 531000, Siena, Italy.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.